News

St. Jude, CardioMEMS, CHAMPION trial, heart failure, reduced ejection fraction

Heart failure patients with reduced ejection fraction experienced significant HF mortality and hospitalization reductions via guideline-directed medical therapy managed by pulmonary artery...

Minneapolis Heart Institute Foundation, PCI, STEMI, late presenters

New research from the Minneapolis Heart Institute Foundation (MHIF) finds that percutaneous coronary intervention for heart attacks can still be beneficial for patients who get to their more than...

Computed tomography, coronary CT angiography, PROMISE trial, ACC

Results from the PROMISE clinical trial confirmed what many cardiologists and radiologists have long suspected to be true: Coronary computed tomographic angiography (coronary CTA) is...

Medtronic, Drug Filled Stent, clinical trial, ACC

Medtronic plc unveiled the preclinical outcomes of its novel Drug-Filled Stent (DFS) at the 64th Annual Scientific Session of the American College of Cardiology (ACC). The preclinical data showed...

AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (DEEP) clinical study have been enrolled and treated at PinnacleHealth CardioVascular...

Researchers at the University of North Carolina (UNC) School of Medicine have found the blood platelet protein Rasa3 is critical to the success of the common anti-platelet drug Plavix. Plavix...

women veterans, heart disease, test, depression, AHA, VA

Women veterans who had specialized heart tests were younger and more likely to be obese, depressed and suffer from post-traumatic stress disorder than male veterans, according to a study published...

A new study has found that high phosphate levels can cause a stress signal inside the cells that line blood vessels, leading to the release of microparticles that promote the formation of blood...

BPH, prostate, interventional radiology, PAE, embolization, SIR

Men with benign prostatic hyperplasia (BPH), have a new, breakthrough treatment option that is less invasive and has fewer complications than other minimally invasive treatments, according to...

An innovative interventional radiology treatment has been found to offer chronic migraine sufferers sustained relief of their headaches, according to research being presented at the Society...

congenital heart, adults, early detection, Penn State Hershey, CHD

At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth...

TAVR, TAVI, acc, ACC.15, corevalve

Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at the American College of Cardiology (ACC) Scientific Session this weekend,...

STS, CHSD, congenital heart, trial, surgery, database, pediatric

The Society of Thoracic Surgeons (STS) has released the first publicly accessible national report of surgical outcomes from its Congenital Heart Surgery Database (CHSD), a component of the STS...

protein, heart failure, trial, RBFox2, cardiac diagnostics, UC San Diego

Researchers at the University of California, San Diego School of Medicine have identified a key piece in the complex molecular puzzle underlying heart failure.

TAVR, study, one-year outcomes, heart valve repair, JAMA, Mayo Clinic

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March...

Astron, Biotronik, BIOFLEX-I, trial, peripheral stents, CRT 2015

Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at the Cardiovascular Research Technologies (CRT) conference in Washington, D.C. The...

Corindus, CorPath, trial, cath lab, PCI, robotic

Corindus Vascular Robotics Inc. announced it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The study is currently enrolling patients at the...

Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of Zontivity (vorapaxar...

OrbusNeich, Combo Dual Therapy Stent, REMEDEE, EGO COMBO, JIM 2015

A three-year review of data on the Combo Dual Therapy Stent was presented at the Joint Interventional Meeting (JIM) 2015 in Rome. These data demonstrate the healing benefits of the Combo Dual...

Biotronik, ProMRI, AFFIRM, trial, ICD, MRI systems, EP Lab

Biotronik announced that its ProMRI and ProMRI AFFIRM studies have been published in Heart Rhythm, the official journal of the Heart Rhythm Society, validating the...